Valuation : Guerbet

Market Cap 97.26M 113M 91.19M 83.25M 157M 10.79B 157M 1.08B 422M 5.45B 424M 415M 18.06B P/E 2026 *
-4.32x
P/E 2027 * 8.39x
Enterprise Value 473M 549M 443M 405M 762M 52.45B 765M 5.26B 2.05B 26.48B 2.06B 2.02B 87.79B EV / Sales 2026 *
0.62x
EV / Sales 2027 * 0.59x
Free-Float
36.58%
Yield 2026 *
-
Yield 2027 * 3.03%
1 day-0.13%
1 week-1.53%
Current month-4.47%
1 month-4.47%
3 months-26.39%
6 months-38.99%
Current year-46.15%
1 week 7.7
Extreme 7.7
7.93
1 month 7.7
Extreme 7.7
8.53
Current year 7.43
Extreme 7.43
15.12
1 year 7.43
Extreme 7.43
20.6
3 years 7.43
Extreme 7.43
40.25
5 years 7.43
Extreme 7.43
45.65
10 years 7.43
Extreme 7.43
90.64
Manager TitleAgeSince
Chief Executive Officer - 02/02/2026
Chief Executive Officer - 22/09/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 44 29/05/2015
Director/Board Member 50 19/05/2017
Director/Board Member 51 22/11/2023
Date Insider Type Main position Quantity % Market Cap.
8/6/26 A Buy

Director

1,185 0.0094%
8/5/26 A Buy

Director

5,027 0.0398%
8/4/26 A Buy

Director

3,788 0.0300%
Change 5-day change 1-year change 3-year change Capi.($)
-0.13%-1.53%-61.98%-64.60% 113M
+0.27%-0.42%-25.56%-3.85% 12.82B
-3.83%-6.27%+9.74%+4.87% 4.41B
-0.20%-5.65%-40.90%-57.06% 1.23B
+1.00%-0.63%-37.51%-40.94% 1.16B
+0.08%-0.89%+20.20%+75.37% 1.11B
-1.14%-1.20%-37.11% - 1.05B
-2.47%+8.21% - - 1.04B
+0.95%-3.68%+28.58%+110.07% 536M
-2.15%-1.50%+58.13% - 297M
Average -0.76%+0.41%-9.60%+3.41% 2.38B
Weighted average by Cap. -0.69%+0.05%-16.26%-0.47%

Financials

2026 *2027 *
Net sales 764M 886M 716M 654M 1.23B 84.72B 1.24B 8.5B 3.32B 42.77B 3.33B 3.26B 142B 798M 926M 748M 683M 1.29B 88.54B 1.29B 8.88B 3.46B 44.69B 3.48B 3.4B 148B
Net income -35.8M -41.55M -33.57M -30.64M -57.72M -3.97B -57.91M -398M -155M -2B -156M -153M -6.65B 8.3M 9.63M 7.78M 7.1M 13.38M 921M 13.43M 92.33M 36.02M 465M 36.16M 35.38M 1.54B
Net Debt 376M 436M 352M 321M 606M 41.66B 608M 4.18B 1.63B 21.03B 1.64B 1.6B 69.73B 370M 430M 347M 317M 597M 41.07B 599M 4.12B 1.61B 20.73B 1.61B 1.58B 68.75B
Logo Guerbet
Guerbet is a European leader in producing and selling contrast products for medical imaging. The group's products make it possible to visualize different organs and the lymphatic and vascular systems of the human body by making them opaque. Net sales break down by product family as follows: - X-ray imaging products (54.4%); - MRI products (32.1%); - other (13.5%): contrast products for echography and nuclear medicine, fine chemicals products. At the end of 2024 the group had 8 production sites located in France (4), the United States (2), Ireland and Brazil. Net sales are distributed geographically as follows: Europe/Middle East/Africa (43.8%), Americas (29.7%) and Asia (26.5%).
Employees
2,700
Date Price Change Volume
31/08/26 7.700 -0.13% 571
28/08/26 €7.710 -0.52% 10,619
27/08/26 €7.750 -0.13% 11,610
26/08/26 €7.760 -2.02% 8,575
25/08/26 €7.920 +1.28% 1,416
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
3
Last Close Price
7.710EUR
Average target price
8.433EUR
Spread / Average Target
+9.38%

Quarterly revenue - Rate of surprise